UK-based Phagenesis is the world’s leading company in the treatment of dysphagia. Dysphagia is a debilitating and often lethal condition in which the patient’s ability to swallow is damaged. Dysphagia can lead to the inhalation of solids or liquids followed by pneumonia. Sufferers may face being fed through a tube indefinitely, reduced life expectancy, and often are treated for depression. Phagenesis has developed the first clinically proven treatment for dysphagia, clinically proven to aid swallowing to Dysphagia patients.